Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedAdded a publication citation for Olutasidenib in IDH1-mutated chondrosarcoma (Nat Commun 2026, 17(1):2224). Removed the Online ahead of print version.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Hepatocellular carcinoma as a related topic and updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 in the page footer.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.2 has been added in place of Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedPublications section added a new PubMed entry for a 2026 Nat Commun article, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check76 days agoChange DetectedAdded a glossary toggle and updated site metadata labels (including Last Update Submitted that Met QC Criteria) with a revision to v3.4.0, while removing the older QC label and adjusting capitalization (No FEAR Act Data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.